Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""CCL20"" wg kryterium: Temat


Tytuł :
CCL20 is a novel ligand for the scavenging atypical chemokine receptor 4.
Autorzy :
Matti C; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland.
D'Uonnolo G; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Artinger M; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland.
Melgrati S; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Salnikov A; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland.
Thelen S; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Purvanov V; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland.
Strobel TD; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland.
Spannagel L; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland.
Thelen M; Institute for Research in Biomedicine, Università della Svizzera italiana, Bellinzona, Switzerland.
Legler DF; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland.; Faculty of Biology, University of Konstanz, Konstanz, Germany.; Theodor Kocher Institute, University of Bern, Bern, Switzerland.
Pokaż więcej
Źródło :
Journal of leukocyte biology [J Leukoc Biol] 2020 Jun; Vol. 107 (6), pp. 1137-1154.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemokine CCL19/*metabolism
Chemokine CCL20/*metabolism
Chemokine CCL21/*metabolism
Chemokines, CC/*metabolism
Receptors, CCR/*metabolism
beta-Arrestins/*genetics
Amino Acid Sequence ; Animals ; B-Lymphocytes/cytology ; B-Lymphocytes/metabolism ; Binding Sites ; Cell Line ; Chemokine CCL19/chemistry ; Chemokine CCL19/genetics ; Chemokine CCL20/chemistry ; Chemokine CCL20/genetics ; Chemokine CCL21/chemistry ; Chemokine CCL21/genetics ; Chemokines, CC/chemistry ; Chemokines, CC/genetics ; HEK293 Cells ; HeLa Cells ; Humans ; Ligands ; Mice ; Mutant Chimeric Proteins/chemistry ; Mutant Chimeric Proteins/genetics ; Mutant Chimeric Proteins/metabolism ; Protein Binding ; Protein Interaction Domains and Motifs ; Protein Isoforms/chemistry ; Protein Isoforms/genetics ; Protein Isoforms/metabolism ; Protein Structure, Secondary ; Receptors, CCR/chemistry ; Receptors, CCR/genetics ; Recombinant Proteins/chemistry ; Recombinant Proteins/genetics ; Recombinant Proteins/metabolism ; Sequence Alignment ; Sequence Homology, Amino Acid ; Species Specificity ; Transfection ; beta-Arrestins/metabolism
Czasopismo naukowe
Tytuł :
Structural basis for chemokine receptor CCR6 activation by the endogenous protein ligand CCL20.
Autorzy :
Wasilko DJ; Discovery Sciences, Medicine Design, Pfizer Worldwide Research and Development, Groton, CT, 06340, USA.
Johnson ZL; Discovery Sciences, Medicine Design, Pfizer Worldwide Research and Development, Groton, CT, 06340, USA.
Ammirati M; Discovery Sciences, Medicine Design, Pfizer Worldwide Research and Development, Groton, CT, 06340, USA.
Che Y; Discovery Sciences, Medicine Design, Pfizer Worldwide Research and Development, Groton, CT, 06340, USA.
Griffor MC; Discovery Sciences, Medicine Design, Pfizer Worldwide Research and Development, Groton, CT, 06340, USA.
Han S; Discovery Sciences, Medicine Design, Pfizer Worldwide Research and Development, Groton, CT, 06340, USA.
Wu H; Discovery Sciences, Medicine Design, Pfizer Worldwide Research and Development, Groton, CT, 06340, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2020 Jun 15; Vol. 11 (1), pp. 3031. Date of Electronic Publication: 2020 Jun 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemokine CCL20/*metabolism
Receptors, CCR6/*chemistry
Receptors, CCR6/*metabolism
Chemokine CCL20/chemistry ; Chemokine CCL20/genetics ; Cryoelectron Microscopy ; Humans ; Ligands ; Protein Binding ; Receptors, CCR6/genetics ; Receptors, G-Protein-Coupled ; Signal Transduction
Czasopismo naukowe
Tytuł :
The rheumatoid synovial environment alters fatty acid metabolism in human monocytes and enhances CCL20 secretion.
Autorzy :
Rodgers LC; Centre of Immunobiology, University of Glasgow, Glasgow, UK.; GLAZgo Discovery Centre, Glasgow, UK.
Cole J; GLAZgo Discovery Centre, Glasgow, UK.
Rattigan KM; Wellcome Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, Glasgow, UK.
Barrett MP; Wellcome Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, Glasgow, UK.; Glasgow Polyomics, Wolfson Wohl Cancer Research Centre, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Kurian N; Respiratory Inflammation and Autoimmune (RIA) Precision Medicine Unit, Precision Medicine, Oncology R&D, AstraZeneca, Gothenburg, Sweden.
McInnes IB; Centre of Immunobiology, University of Glasgow, Glasgow, UK.
Goodyear CS; Centre of Immunobiology, University of Glasgow, Glasgow, UK.; GLAZgo Discovery Centre, Glasgow, UK.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2020 Apr 01; Vol. 59 (4), pp. 869-878.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cellular Microenvironment*
Synovial Fluid*
Arthritis, Rheumatoid/*metabolism
Chemokine CCL20/*metabolism
Fatty Acids/*metabolism
Hypoxia/*metabolism
Monocytes/*metabolism
Carnitine/pharmacology ; Chemokine CCL20/drug effects ; Chromatography, Liquid ; Enzyme Inhibitors/pharmacology ; Epoxy Compounds/pharmacology ; Gene Expression Profiling ; Humans ; In Vitro Techniques ; Lipopolysaccharides/pharmacology ; Mass Spectrometry ; Metabolomics ; Microarray Analysis ; Monocytes/drug effects ; Synovial Membrane/metabolism
Czasopismo naukowe
Tytuł :
Inflammation-related plasma and CSF biomarkers for multiple sclerosis.
Autorzy :
Huang J; Neuroimmunology Unit, Center of Molecular Medicine, Department of Clinical Neuroscience, Karolinska University Hospital, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Khademi M; Neuroimmunology Unit, Center of Molecular Medicine, Department of Clinical Neuroscience, Karolinska University Hospital, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Fugger L; Oxford Centre for Neuroinflammation, Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, United Kingdom.; Nuffield Department of Clinical Neurosciences, Division of Clinical Neurology, University of Oxford, Oxford OX3 9DU, United Kingdom.
Lindhe Ö; Olink Proteomics AB, SE-751 83 Uppsala, Sweden.
Novakova L; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburg, Sweden.
Axelsson M; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburg, Sweden.
Malmeström C; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburg, Sweden.
Constantinescu C; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburg, Sweden.
Lycke J; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburg, Sweden.
Piehl F; Neuroimmunology Unit, Center of Molecular Medicine, Department of Clinical Neuroscience, Karolinska University Hospital, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Olsson T; Neuroimmunology Unit, Center of Molecular Medicine, Department of Clinical Neuroscience, Karolinska University Hospital, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
Kockum I; Neuroimmunology Unit, Center of Molecular Medicine, Department of Clinical Neuroscience, Karolinska University Hospital, Karolinska Institutet, SE-171 77 Stockholm, Sweden; .
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Jun 09; Vol. 117 (23), pp. 12952-12960. Date of Electronic Publication: 2020 May 26.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Chemokine CCL11/*analysis
Chemokine CCL20/*blood
Inflammation/*immunology
Multiple Sclerosis/*diagnosis
Adult ; Biomarkers/blood ; Biomarkers/cerebrospinal fluid ; Case-Control Studies ; Chemokine CCL11/immunology ; Chemokine CCL20/immunology ; Cohort Studies ; Female ; Humans ; Inflammation/blood ; Inflammation/cerebrospinal fluid ; Male ; Middle Aged ; Multiple Sclerosis/blood ; Multiple Sclerosis/cerebrospinal fluid ; Multiple Sclerosis/immunology ; Prognosis ; Proteomics ; Reproducibility of Results ; Severity of Illness Index ; Young Adult
Czasopismo naukowe
Tytuł :
The CCL20 and CCR6 axis in psoriasis.
Autorzy :
Furue K; Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ito T; Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tsuji G; Research and Clinical Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka, Japan.
Nakahara T; Division of Skin Surface Sensing, Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Furue M; Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.; Research and Clinical Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka, Japan.; Division of Skin Surface Sensing, Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Pokaż więcej
Źródło :
Scandinavian journal of immunology [Scand J Immunol] 2020 Mar; Vol. 91 (3), pp. e12846. Date of Electronic Publication: 2019 Nov 24.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Disease Susceptibility*
Chemokine CCL20/*metabolism
Psoriasis/*etiology
Psoriasis/*metabolism
Receptors, CCR6/*metabolism
Animals ; Biomarkers ; Chemokine CCL20/genetics ; Gene Expression Regulation/drug effects ; Humans ; Molecular Targeted Therapy ; Psoriasis/diagnosis ; Psoriasis/therapy ; Receptors, CCR6/genetics ; Signal Transduction/drug effects
Czasopismo naukowe
Tytuł :
Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides.
Autorzy :
Li HJ; School of Medicine, Fu Jen Catholic University, New Taipei City, 24205, Taiwan.
Wu NL; Department of Medicine, Mackay Medical College, New Taipei City, 25245, Taiwan.; Department of Dermatology, Mackay Memorial Hospital, Taipei, 10449, Taiwan.; Mackay Junior College of Medicine, Nursing, and Management, New Taipei City, 25245, Taiwan.
Pu CM; Division of Plastic Surgery, Department of Surgery, Cathay General Hospital, Taipei, 10630, Taiwan.
Hsiao CY; Department of Nutrition and Health Sciences, Research Center for Food and Cosmetic Safety, and Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology, Taoyuan, 33303, Taiwan.; Aesthetic Medical Center, Department of Dermatology, Chang Gung Memorial Hospital, Taoyuan, 33305, Taiwan.
Chang DC; Department of Mathematics and Statistics and Department of Computer Science, Georgetown University, Washington, DC, 20057, USA.
Hung CF; School of Medicine, Fu Jen Catholic University, New Taipei City, 24205, Taiwan. .; Ph.D. Program in Pharmaceutical Biotechnology, Fu Jen University, New Taipei City, 24205, Taiwan. .; MS Program in Transdisciplinary Long Term Care, Fu-Jen Catholic University, New Taipei City, 24205, Taiwan. .; Department of Fragrance and Cosmetic Science, Kaohsiung Medical University, Kaohsiung, 80708, Taiwan. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Feb 19; Vol. 10 (1), pp. 2932. Date of Electronic Publication: 2020 Feb 19.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antimicrobial Cationic Peptides/*metabolism
Chemokine CCL20/*metabolism
Flavonoids/*therapeutic use
Imiquimod/*adverse effects
Inflammation/*drug therapy
Psoriasis/*chemically induced
Psoriasis/*drug therapy
Skin/*pathology
Animals ; Chemokine CCL20/genetics ; Disease Models, Animal ; Down-Regulation/drug effects ; Epidermis/pathology ; Flavonoids/chemistry ; Flavonoids/pharmacology ; Humans ; Hyperplasia ; Interleukin-17/metabolism ; Interleukins/metabolism ; Keratinocytes/drug effects ; Keratinocytes/metabolism ; MAP Kinase Signaling System/drug effects ; Male ; Mice, Inbred BALB C ; NF-kappa B/metabolism ; Phosphorylation/drug effects ; Psoriasis/pathology ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Skin/drug effects ; Skin/physiopathology ; Tumor Necrosis Factor-alpha/metabolism
Czasopismo naukowe
Tytuł :
Does mechanical scratching cause the recruitment of T-helper 17 cells in atopic dermatitis?
Autorzy :
Furue K; Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Ito T; Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Tsuji G; Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.; Division of Skin Surface Sensing, Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Esaki H; Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kido-Nakahara M; Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.
Nakahara T; Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.; Research and Clinical Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka, Japan.
Furue M; Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.; Division of Skin Surface Sensing, Department of Dermatology, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan.; Research and Clinical Center for Yusho and Dioxin, Kyushu University Hospital, Fukuoka, Japan.
Pokaż więcej
Źródło :
The Journal of dermatology [J Dermatol] 2019 Nov; Vol. 46 (11), pp. e436-e437. Date of Electronic Publication: 2019 Jul 11.
Typ publikacji :
Letter
MeSH Terms :
Chemokine CCL20/*metabolism
Dermatitis, Atopic/*immunology
Pruritus/*immunology
Skin/*pathology
Th17 Cells/*immunology
Antibodies, Monoclonal, Humanized/pharmacology ; Antibodies, Monoclonal, Humanized/therapeutic use ; Chemokine CCL20/immunology ; Dermatitis, Atopic/complications ; Dermatitis, Atopic/drug therapy ; Dermatitis, Atopic/pathology ; Humans ; Pruritus/drug therapy ; Pruritus/pathology ; Signal Transduction/drug effects ; Signal Transduction/immunology ; Skin/drug effects ; Skin/immunology ; Treatment Outcome ; Up-Regulation/drug effects ; Up-Regulation/immunology
Opinia redakcyjna
Tytuł :
DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
Autorzy :
Guo W; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Li H; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Liu H; Research Laboratory of Biomedical Engineering, The TCM Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Ma X; Department of General Surgery, The TCM Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Yang S; Department of Cardiovascular Medicine, The TCM Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, P.R. China.
Wang Z; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China.
Pokaż więcej
Źródło :
Oncology reports [Oncol Rep] 2019 Sep; Vol. 42 (3), pp. 1075-1089. Date of Electronic Publication: 2019 Jul 05.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Carcinoma, Hepatocellular/*pathology
Chemokine CCL20/*metabolism
GTPase-Activating Proteins/*metabolism
Liver Neoplasms/*pathology
Neoplasm Proteins/*metabolism
Neovascularization, Pathologic/*pathology
Receptors, CCR6/*metabolism
Aged ; Apoptosis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/metabolism ; Case-Control Studies ; Cell Proliferation ; Chemokine CCL20/antagonists & inhibitors ; Chemokine CCL20/genetics ; Female ; Follow-Up Studies ; GTPase-Activating Proteins/antagonists & inhibitors ; GTPase-Activating Proteins/genetics ; Gene Expression Profiling ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/metabolism ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Proteins/antagonists & inhibitors ; Neoplasm Proteins/genetics ; Neovascularization, Pathologic/genetics ; Neovascularization, Pathologic/metabolism ; Prognosis ; RNA, Small Interfering/genetics ; Receptors, CCR6/antagonists & inhibitors ; Receptors, CCR6/genetics ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling.
Autorzy :
Wang D; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, 450052, People's Republic of China.
Yang L; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, 450052, People's Republic of China.
Yu W; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, 450052, People's Republic of China.
Wu Q; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, 450052, People's Republic of China.
Lian J; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, 450052, People's Republic of China.
Li F; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, 450052, People's Republic of China.
Liu S; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, 450052, People's Republic of China.
Li A; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, 450052, People's Republic of China.
He Z; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.; Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, 450052, People's Republic of China.
Liu J; Department of Anorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.
Sun Z; Department of Anorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.
Yuan W; Department of Anorectal Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China.
Zhang Y; Biotherapy Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China. .; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China. .; Henan Key Laboratory for Tumor Immunology and Biotherapy, Zhengzhou, Henan, 450052, People's Republic of China. .; School of Life Sciences, Zhengzhou University, Zhengzhou, Henan, 450001, People's Republic of China. .
Pokaż więcej
Źródło :
Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Aug 08; Vol. 7 (1), pp. 215. Date of Electronic Publication: 2019 Aug 08.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*pharmacology
CCAAT-Enhancer-Binding Protein-beta/*metabolism
Chemokine CCL20/*immunology
Colorectal Neoplasms/*immunology
Forkhead Box Protein O1/*metabolism
NF-kappa B/*metabolism
T-Lymphocytes, Regulatory/*immunology
Animals ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Cell Line, Tumor ; Cell Proliferation/physiology ; Chemokine CCL20/metabolism ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/metabolism ; Colorectal Neoplasms/pathology ; Disease Models, Animal ; Drug Resistance, Neoplasm ; Female ; Fluorouracil/administration & dosage ; HCT116 Cells ; Humans ; Leucovorin/administration & dosage ; Male ; Mice ; Mice, SCID ; Middle Aged ; Organoplatinum Compounds/administration & dosage ; Signal Transduction/immunology ; T-Lymphocytes, Regulatory/metabolism ; T-Lymphocytes, Regulatory/pathology ; Transfection ; Xenograft Model Antitumor Assays
SCR Protocol :
Folfox protocol
Czasopismo naukowe
Tytuł :
Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation.
Autorzy :
Lee AC; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California San Diego, La Jolla, CA 92093, USA.; Research Service, VA San Diego Healthcare System San Diego, La Jolla, CA 92161, USA.
Chakladar J; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California San Diego, La Jolla, CA 92093, USA.; Research Service, VA San Diego Healthcare System San Diego, La Jolla, CA 92161, USA.
Li WT; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California San Diego, La Jolla, CA 92093, USA.; Research Service, VA San Diego Healthcare System San Diego, La Jolla, CA 92161, USA.
Chen C; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California San Diego, La Jolla, CA 92093, USA.; Research Service, VA San Diego Healthcare System San Diego, La Jolla, CA 92161, USA.
Chang EY; Department of Radiology, Radiology Service, VA San Diego Healthcare System San Diego, University of California San Diego, La Jolla, CA 92093, USA.
Wang-Rodriguez J; Department of Pathology, Pathology Service, VA San Diego Healthcare System San Diego, University of California San Diego, La Jolla, CA 92093, USA.
Ongkeko WM; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California San Diego, La Jolla, CA 92093, USA.; Research Service, VA San Diego Healthcare System San Diego, La Jolla, CA 92161, USA.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2020 Jul 31; Vol. 21 (15). Date of Electronic Publication: 2020 Jul 31.
Typ publikacji :
Journal Article
MeSH Terms :
Electronic Nicotine Delivery Systems*
Tobacco Smoking*
Immune System/*metabolism
Peptidyl-Dipeptidase A/*metabolism
Adult ; Betacoronavirus/isolation & purification ; Bronchi/cytology ; Chemokine CCL20/genetics ; Chemokine CCL20/metabolism ; Coronavirus Infections/pathology ; Coronavirus Infections/virology ; Epithelial Cells/cytology ; Epithelial Cells/metabolism ; Humans ; Interleukin-1beta/metabolism ; Interleukin-8/genetics ; Interleukin-8/metabolism ; Middle Aged ; Nod2 Signaling Adaptor Protein/genetics ; Nod2 Signaling Adaptor Protein/metabolism ; Pandemics ; Pneumonia, Viral/pathology ; Pneumonia, Viral/virology ; Up-Regulation ; Young Adult
SCR Disease Name :
COVID-19
Czasopismo naukowe
Tytuł :
ERRα Expression in Bone Metastases Leads to an Exacerbated Antitumor Immune Response.
Autorzy :
Bouchet M; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France.
Lainé A; University of Lyon-France.; Tumor Escape Resistance and Immunity Department, CRCL, INSERM 1052 CNRS 5286, Centre Léon Bérard, Labex DEVweCAN, Lyon, France.
Boyault C; Institute for Advanced Biosciences, UMR5209-INSERM1302, La Tronche, France.
Proponnet-Guerault M; Institute for Advanced Biosciences, UMR5209-INSERM1302, La Tronche, France.
Meugnier E; INSERMU1060-INRA-U1397, Lyon, France.
Bouazza L; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France.
Kan CWS; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France.
Geraci S; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France.
El-Moghrabi S; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France.
Hernandez-Vargas H; Tumor Escape Resistance and Immunity Department, CRCL, INSERM 1052 CNRS 5286, Centre Léon Bérard, Labex DEVweCAN, Lyon, France.
Benetollo C; University of Lyon-France.; INSERM-UMR5292 INSERM U1028, Lyon, France.
Yoshiko Y; Department of Calcified Tissue Biology, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Japan.
Duterque-Coquillaud M; University of Lille, Institut Pasteur de Lille, CNRS-UMR9020-INSERM-UMR1277, Lille, France.
Clézardin P; INSERM-UMR1033, Labex DEVweCAN, Lyon, France.; University of Lyon-France.
Marie JC; University of Lyon-France. .; Tumor Escape Resistance and Immunity Department, CRCL, INSERM 1052 CNRS 5286, Centre Léon Bérard, Labex DEVweCAN, Lyon, France.
Bonnelye E; INSERM-UMR1033, Labex DEVweCAN, Lyon, France. .; University of Lyon-France.
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2020 Jul 01; Vol. 80 (13), pp. 2914-2926. Date of Electronic Publication: 2020 May 04.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*metabolism
Bone Neoplasms/*prevention & control
Breast Neoplasms/*prevention & control
Receptors, Estrogen/*metabolism
T-Lymphocytes/*immunology
Tumor Microenvironment/*immunology
Animals ; Apoptosis ; Biomarkers, Tumor/genetics ; Bone Neoplasms/immunology ; Bone Neoplasms/metabolism ; Bone Neoplasms/secondary ; Breast Neoplasms/immunology ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Cell Proliferation ; Chemokine CCL17/genetics ; Chemokine CCL17/metabolism ; Chemokine CCL20/genetics ; Chemokine CCL20/metabolism ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Mice ; Mice, Inbred BALB C ; Mice, Nude ; Prognosis ; Receptors, Estrogen/genetics ; Signal Transduction ; Transforming Growth Factor beta3/genetics ; Transforming Growth Factor beta3/metabolism ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Relationship between serum and synovial fluid CCL20 concentrations with disease severity in primary knee osteoarthritis.
Autorzy :
Guan J; Department of Orthopedic Surgery, Third Hospital of Shi Jiazhuang, Shi Jiazhuang, Hebei Province, China.
Li Y; Department of Orthopedic Surgery, Third Hospital of Shi Jiazhuang, Shi Jiazhuang, Hebei Province, China.
Ding LB; Department of Orthopedic Surgery, Third Hospital of Shi Jiazhuang, Shi Jiazhuang, Hebei Province, China.
Liu GY; Department of Orthopedic Surgery, Third Hospital of Shi Jiazhuang, Shi Jiazhuang, Hebei Province, China.
Zheng XF; Department of Orthopedic Surgery and Sports Medicine Center, First Affiliated Hospital of Jinan University, GuangZhou, Guang Dong Province, China.
Xue W; Department of Orthopedics, Handan Central Hospital, Handan Hebei Province, China.
Wang HJ; Department of Orthopedic Surgery and Sports Medicine Center, First Affiliated Hospital of Jinan University, GuangZhou, Guang Dong Province, China.
Pokaż więcej
Źródło :
Journal of musculoskeletal & neuronal interactions [J Musculoskelet Neuronal Interact] 2019 Sep 01; Vol. 19 (3), pp. 326-332.
Typ publikacji :
Journal Article
MeSH Terms :
Chemokine CCL20/*metabolism
Osteoarthritis, Knee/*pathology
Aged ; Biomarkers/analysis ; Chemokine CCL20/analysis ; Female ; Humans ; Male ; Middle Aged ; Osteoarthritis, Knee/immunology ; Osteoarthritis, Knee/metabolism ; Synovial Fluid/chemistry ; Synovial Fluid/immunology
Czasopismo naukowe
Tytuł :
The combined effect of IL-17F and CCL20 gene polymorphism in susceptibility to multiple sclerosis in Egypt.
Autorzy :
El Sharkawi FZ; Biochemistry Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt. Electronic address: .
Ali SA; Biochemistry Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt. Electronic address: .
Hegazy MI; Neurology Department, Faculty of Medicine, Cairo University, Cairo, Egypt. Electronic address: .
Atya HB; Biochemistry Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt. Electronic address: .
Pokaż więcej
Źródło :
Gene [Gene] 2019 Feb 15; Vol. 685, pp. 164-169. Date of Electronic Publication: 2018 Nov 03.
Typ publikacji :
Journal Article
MeSH Terms :
Genetic Association Studies*
Genetic Predisposition to Disease*
Polymorphism, Single Nucleotide*
Chemokine CCL20/*genetics
Interleukin-17/*genetics
Multiple Sclerosis/*genetics
Alleles ; Case-Control Studies ; Chemokine CCL20/blood ; Egypt ; Female ; Genotype ; Humans ; Interleukin-17/blood ; Male ; Odds Ratio
Czasopismo naukowe
Tytuł :
Circulating CCL20: A potential biomarker for active vitiligo together with the number of Th1/17 cells.
Autorzy :
Zhang L; Department of Dermatology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, PR China.
Kang Y; Department of Dermatology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, PR China.
Chen S; Department of Dermatology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, PR China.
Wang L; Department of Laboratory Medicine, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, PR China.
Jiang M; Department of Dermatology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, PR China. Electronic address: .
Xiang L; Department of Dermatology, Huashan Hospital, Fudan University, 12 Wulumuqi Zhong Road, Shanghai, 200040, PR China. Electronic address: .
Pokaż więcej
Źródło :
Journal of dermatological science [J Dermatol Sci] 2019 Feb; Vol. 93 (2), pp. 92-100. Date of Electronic Publication: 2019 Jan 03.
Typ publikacji :
Journal Article
MeSH Terms :
Th1 Cells*
Th17 Cells*
Chemokine CCL20/*blood
Vitiligo/*diagnosis
Adult ; Biomarkers/blood ; Biomarkers/metabolism ; Chemokine CCL20/metabolism ; Cohort Studies ; Female ; Humans ; Lymphocyte Count ; Male ; Middle Aged ; Receptors, CCR6/metabolism ; Severity of Illness Index ; Skin/pathology ; T-Lymphocytes, Cytotoxic ; Vitiligo/blood ; Vitiligo/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
The CC chemokines CCL8, CCL13 and CCL20 are local inflammatory biomarkers of HLA-B27-associated uveitis.
Autorzy :
Abu El-Asrar AM; Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.; Dr. Nasser Al-Rashid Research Chair in Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Berghmans N; Rega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, KU Leuven, Leuven, Belgium.
Al-Obeidan SA; Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Gikandi PW; Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Opdenakker G; Rega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, KU Leuven, Leuven, Belgium.
Van Damme J; Rega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, KU Leuven, Leuven, Belgium.
Struyf S; Rega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, KU Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
Acta ophthalmologica [Acta Ophthalmol] 2019 Feb; Vol. 97 (1), pp. e122-e128. Date of Electronic Publication: 2018 Sep 21.
Typ publikacji :
Journal Article
MeSH Terms :
Aqueous Humor/*metabolism
Chemokine CCL20/*metabolism
Chemokine CCL8/*metabolism
HLA-B27 Antigen/*immunology
Monocyte Chemoattractant Proteins/*metabolism
Uveitis/*immunology
Aqueous Humor/immunology ; Biomarkers/metabolism ; Chemokine CCL20/immunology ; Chemokine CCL8/immunology ; Chemokines, CC/immunology ; Chemokines, CC/metabolism ; Fluorescein Angiography ; Fundus Oculi ; Humans ; Monocyte Chemoattractant Proteins/immunology ; Ophthalmoscopy ; Uveitis/diagnosis ; Uveitis/metabolism
Czasopismo naukowe
Tytuł :
Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer.
Autorzy :
Ranasinghe R; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7248, Australia. .
Eri R; School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania 7248, Australia. .
Pokaż więcej
Źródło :
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2018 Nov 16; Vol. 54 (5). Date of Electronic Publication: 2018 Nov 16.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Immunomodulation*
Molecular Targeted Therapy*
Autoimmune Diseases/*drug therapy
Chemokine CCL20/*antagonists & inhibitors
Inflammation/*drug therapy
Neoplasms/*drug therapy
Receptors, CCR6/*antagonists & inhibitors
Antibodies/therapeutic use ; Autoimmune Diseases/immunology ; Chemokine CCL20/immunology ; Drug Discovery ; Humans ; Inflammation/immunology ; Molecular Mimicry/immunology ; Neoplasms/immunology ; Receptors, Artificial/therapeutic use ; Receptors, CCR6/immunology ; T-Lymphocytes, Regulatory/immunology ; Th17 Cells/immunology
Czasopismo naukowe
Tytuł :
Mechanism of Jinrong granule in inhibiting the invasion of breast cancer cells by the CXCL-1-CXCR2/CCL20 pathway.
Autorzy :
Guo L; Department of Galactophore, The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong Province, China.
Situ HL; Department of Galactophore, The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong Province, China.
Wang ZY; Research and Innovation Team of Department of Galactophore, The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong Province, China.
Lin Y; Department of Galactophore, The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong Province, China.
Chen QJ; Department of Galactophore, The Second Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine, Guangzhou, Guangdong Province, China.
Pokaż więcej
Źródło :
Journal of biological regulators and homeostatic agents [J Biol Regul Homeost Agents] 2020 May-Jun; Vol. 34 (3), pp. 969-976.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Apoptosis ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Chemokine CCL20 ; Chemokine CXCL1 ; Gene Expression Regulation, Neoplastic ; Humans ; Neoplasm Invasiveness ; Receptors, Interleukin-8B ; Signal Transduction
Czasopismo naukowe
Tytuł :
Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates.
Autorzy :
Laffan SB; In vitro In vivo Translation (IVIVT), R&D, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.
Thomson AS; Biopharm Analytical Science, R&D Platform Technology and Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.
Mai S; Biopharm Analytical Science, R&D Platform Technology and Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.
Fishman C; In vitro In vivo Translation (IVIVT), R&D, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.
Kambara T; Pathology, IVIVT, R&D, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.
Nistala K; Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, United Kingdom.
Raymond JT; Charles River Laboratories, Inc., Frederick, Maryland, United States of America.
Chen S; Biopharm Analytical Science, R&D Platform Technology and Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.
Ramani T; Envigo CRS, Inc., Princeton, New Jersey, United States of America.
Pageon L; Envigo CRS, Inc., Princeton, New Jersey, United States of America.
Polsky R; Biopharm Analytical Science, R&D Platform Technology and Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.
Watkins M; In vitro In vivo Translation (IVIVT), R&D, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.
Ottolangui G; Biopharm Molecular Discovery, R&D Platform Technology and Science, GlaxoSmithKline, Stevenage, United Kingdom.
White JR; Biopharm Analytical Science, R&D Platform Technology and Science, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America.
Maier C; In vitro In vivo Translation (IVIVT), R&D, GlaxoSmithKline, Collegeville, Pennsylvania, United States of America.
Herdman M; Clinical Pharmacology and Experimental Medicine, GlaxoSmithKline, Stevenage, United Kingdom.
Bouma G; Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, United Kingdom.; Clinical Pharmacology and Experimental Medicine, GlaxoSmithKline, Stevenage, United Kingdom.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Apr 23; Vol. 15 (4), pp. e0231655. Date of Electronic Publication: 2020 Apr 23 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal/*therapeutic use
Antibodies, Monoclonal, Humanized/*therapeutic use
Chemokine CCL20/*immunology
Complement System Proteins/*immunology
Immune Complex Diseases/*drug therapy
Immune Complex Diseases/*immunology
Immunoconjugates/*therapeutic use
Animals ; Antibodies, Monoclonal/toxicity ; Chronic Disease ; Crystallization ; Endpoint Determination ; Female ; Humans ; Inflammation/immunology ; Inflammation/pathology ; Macaca fascicularis
Czasopismo naukowe
Tytuł :
CCR6 controls autoimmune but not innate immunity-driven experimental arthritis.
Autorzy :
Bonelli M; Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Puchner A; Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Göschl L; Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Hayer S; Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Niederreiter B; Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Steiner G; Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Tillmann K; Division of Biomedical Research, Medical University of Vienna, Vienna, Austria.
Plasenzotti R; Division of Biomedical Research, Medical University of Vienna, Vienna, Austria.
Podesser B; Division of Biomedical Research, Medical University of Vienna, Vienna, Austria.
Georgel P; NSERM UMR_S 1109, Université de Strasbourg, France.
Smolen J; Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Scheinecker C; Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Blüml S; Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria.
Pokaż więcej
Źródło :
Journal of cellular and molecular medicine [J Cell Mol Med] 2018 Nov; Vol. 22 (11), pp. 5278-5285. Date of Electronic Publication: 2018 Aug 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Arthritis, Experimental/*genetics
Arthritis, Rheumatoid/*genetics
Autoimmune Diseases/*genetics
Chemokine CCL20/*genetics
Receptors, CCR6/*genetics
Animals ; Arthritis, Experimental/immunology ; Arthritis, Experimental/pathology ; Arthritis, Rheumatoid/immunology ; Arthritis, Rheumatoid/pathology ; Autoimmune Diseases/immunology ; Autoimmune Diseases/pathology ; Chemokine CCL20/immunology ; Humans ; Immunity, Innate/genetics ; Mice ; Receptors, CCR6/immunology ; Synovial Membrane/immunology ; Synovial Membrane/pathology
Czasopismo naukowe
Tytuł :
Chemokine CCL20 plasmid improves protective efficacy of the Montanide ISA™ 206 adjuvanted foot-and-mouth disease vaccine in mice model.
Autorzy :
Jayeshbhai C; Immunology Lab, FMD QCQA Unit, Indian Veterinary Research Institute, Bangalore 560024, India.
Hajam IA; Immunology Lab, FMD QCQA Unit, Indian Veterinary Research Institute, Bangalore 560024, India; College of Veterinary Medicine, Chonbuk National University, Iksan, Republic of Korea.
Verma AK; Immunology Lab, FMD QCQA Unit, Indian Veterinary Research Institute, Bangalore 560024, India.
Bhanuprakash V; Immunology Lab, FMD QCQA Unit, Indian Veterinary Research Institute, Bangalore 560024, India.
Kondabattula G; Immunology Lab, FMD QCQA Unit, Indian Veterinary Research Institute, Bangalore 560024, India. Electronic address: .
Kishore S; Immunology Lab, FMD QCQA Unit, Indian Veterinary Research Institute, Bangalore 560024, India. Electronic address: .
Pokaż więcej
Źródło :
Vaccine [Vaccine] 2018 Aug 23; Vol. 36 (35), pp. 5318-5324. Date of Electronic Publication: 2018 Jul 24.
Typ publikacji :
Journal Article
MeSH Terms :
Chemokine CCL20/*metabolism
Foot-and-Mouth Disease/*prevention & control
Foot-and-Mouth Disease Virus/*immunology
Foot-and-Mouth Disease Virus/*pathogenicity
Plasmids/*genetics
Animals ; Antibodies, Neutralizing/immunology ; Chemokine CCL20/genetics ; Female ; Foot-and-Mouth Disease/immunology ; Mice ; Vaccines, Inactivated/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies